Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.48 +0.19 (+0.75%)
Official Closing Price Updated: 7:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
‘Somebody Knows Something:’ Viking Therapeutics Stock Pops To Nearly 3-Month High As Retail Traders Intensely Speculate On M&A Scenarios ↗
Via Stocktwits
News headline image
1 Large-Cap Stock for Long-Term Investors and 2 We Turn Down
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an... 
Via StockStory
News headline image
Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Novo Nordisk Rises Despite Metsera Loss, Slashes Wegovy Price In India ↗
Novo Nordisk shares are trading higher on Tuesday. The company recently lost its bidding war for Metsera Inc. 
Via Benzinga
Pfizer CEO Reportedly Drops F-Bomb On Live TV Discussing Seagen, Metsera Deals ↗
Via Stocktwits
News headline image
Most active S&P500 stocks in Tuesday's session ↗
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
News headline image
Curious about the most active stocks on Tuesday? ↗
Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume! 
Via Chartmill
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
AI Takes Center Stage: LogiPharma Report Reveals Pharmaceutical Supply Chains Embrace Intelligent Automation
The pharmaceutical industry, long known for its meticulous processes and stringent regulations, is undergoing a profound transformation driven by Artificial Intelligence. A recent LogiPharma AI Report... 
Via TokenRing AI
Topics Artificial Intelligence Economy Fraud
News headline image
Where Will Pfizer Be in 3 Years? ↗
Pfizer is working to deal with typical business issues in the drug space, but its attempt at a solution has become very complicated. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market? ↗
Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs. 
Via The Motley Fool
News headline image
Shutdown Deal Breathes New Life Into Wall Street ↗
The prospect of a quick end to the US government shutdown has rekindled investor confidence. Tech rebounds, semiconductors sprint ahead, and insurers feel political pressure building. Meanwhile, all... 
Via Chartmill
News headline image
Why a Strong Quarter Wasn't Enough to Send Shares of Pfizer Soaring ↗
Pfizer not only beat expectations last quarter, but also boosted its guidance. 
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
The Top 5 Analyst Questions From Pfizer’s Q3 Earnings Call
Pfizer’s third quarter results reflected ongoing challenges in its COVID-19 franchise, but management pointed to solid growth in non-COVID products and disciplined cost management as key drivers of... 
Via StockStory
Topics Earnings
News headline image
Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds
New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Looking for the most active stocks in the S&P500 index on Monday? ↗
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
News headline image
These stocks are the most active in today's session ↗
Monday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity! 
Via Chartmill
News headline image
AI’s Next Frontier: Key Stocks to Watch Amidst Market Shifts and Technological Leaps
The artificial intelligence (AI) sector is currently navigating a period of unprecedented dynamism, characterized by explosive technological advancements, massive capital inflows, and a palpable... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Market Resilience Tested: How Investors Can Navigate U.S. Government Shutdowns
As the U.S. political landscape continues to present its unique set of challenges, the specter of a government shutdown remains a perennial concern for investors. These periods, marked by a cessation... 
Via MarketMinute
Topics Bonds Economy Government
News headline image
Wall Street Cheers as Senate Vote Signals End to Record-Breaking US Government Impasse
Global equity markets have surged in early November 2025, fueled by renewed optimism that the United States government's historic shutdown, which commenced on October 1, 2025, may finally be nearing... 
Via MarketMinute
Topics Economy Workforce
News headline image
Cogent Biosciences' Lead Cancer Drug Cuts Disease Progression Or Death Risk By 50% In Stomach Cancer Trial ↗
Cogent Biosciences stock rises as bezuclastinib plus Sutent shows 50% lower progression risk and strong efficacy in Phase 3 GIST trial. 
Via Benzinga
News headline image
Metsera Tumbles After The Pfizer-Novo Buyout Battle Ends At $10 Billion ↗
The final bid, at $10 billion, is expected to wrap up after Nov. 13 with the next shareholders' vote. 
Via Investor's Business Daily
Topics Initial Public Offering
News headline image
Markets Breathe Sigh of Relief as Historic Government Shutdown Nears Resolution
Washington D.C. – November 10, 2025 – The United States stock market is experiencing a significant uplift today, as news of an impending resolution to the nation's longest-ever government shutdown... 
Via MarketMinute
Topics Economy Government
News headline image
Monday.Com, Metsera, Profrac Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Viasat Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
3 Cash-Producing Stocks We Think Twice About
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
News headline image
Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith ↗
Novo investors on Stocktwits praised new CEO Mike Doustdar as “dynamic,” saying they remain confident in Novo’s long-term obesity and diabetes pipeline despite short-term setbacks. 
Via Stocktwits
News headline image
Market Reels from Volatility and Mixed Signals: A Deep Dive into Investor Unease
The past week, from November 1st to November 8th, 2025, has witnessed a significant shift in global market sentiment, moving decisively towards a "risk-off" stance. Investors are grappling with... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
2 No-Brainer Dividend Stocks to Buy With $100 in November ↗
There's no need to break the bank to get your hands on excellent dividend payers. 
Via The Motley Fool
Topics Economy World Trade
News headline image
Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here's What This Means for Investors. ↗
Weight loss drugs generated about $10 billion for Lilly in the most recent quarter. 
Via The Motley Fool
Topics Government
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.